Cargando…
Screening and validation of novel serum panel of microRNA in stratification of prostate cancer
BACKGROUND: Owing to the heterogeneous nature of prostate cancer (PCa) and errors in the characterization of the disease, researchers have been trying to unveil molecular biomarkers like microRNA (miRNA) as diagnostic markers. The purpose of our study is to demonstrate the precision of a panel of mi...
Autores principales: | Manoj, Anveshika, Ahmad, Mohammad K., Prasad, Gautam, Kumar, Durgesh, Mahdi, Abbas A., Kumar, Manoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513910/ https://www.ncbi.nlm.nih.gov/pubmed/37745909 http://dx.doi.org/10.1016/j.prnil.2023.06.002 |
Ejemplares similares
-
Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment
por: Kunwar, Arzu, et al.
Publicado: (2023) -
MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer
por: Zhang, Shiyu, et al.
Publicado: (2021) -
Improved risk stratification in prevention by use of a panel of selected circulating microRNAs
por: Keller, Till, et al.
Publicado: (2017) -
MicroRNAs in the development and neoplasia of the mammary gland
por: Jena, Manoj Kumar
Publicado: (2017) -
A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma
por: Li, Rongkang, et al.
Publicado: (2022)